ASCO 2018 Preview – what to expect from this year’s conference
ASCO 2018, cancer, CAR T, Celgene, Eisai, first-line lung cancer, Immunotherapies, Keytruda, Loxo Oncology, Merck & Co, Novartis, Oncology
0 Comment